Efficient in vitro oxaliplatin delivery with functionalized single-walled carbon nanotube for enhanced colon cancer treatment

Abstract Background Site-specific transport of medicinal products to malignant cells and tissues is an intriguing area since it has an ability to safeguard healthy cells. Selective upregulation of folate receptors on colon cancer cells is usual. Consequently, folate receptors have become one of exte...

Full description

Bibliographic Details
Main Authors: Dheeraj S. Randive, Kiran P. Shejawal, Somnath D. Bhinge, Mangesh A. Bhutkar, Namdeo R. Jadhav, Sandeep B. Patil, Sameer J. Nadaf
Format: Article
Language:English
Published: SpringerOpen 2023-10-01
Series:Future Journal of Pharmaceutical Sciences
Subjects:
Online Access:https://doi.org/10.1186/s43094-023-00543-8
_version_ 1827724150240706560
author Dheeraj S. Randive
Kiran P. Shejawal
Somnath D. Bhinge
Mangesh A. Bhutkar
Namdeo R. Jadhav
Sandeep B. Patil
Sameer J. Nadaf
author_facet Dheeraj S. Randive
Kiran P. Shejawal
Somnath D. Bhinge
Mangesh A. Bhutkar
Namdeo R. Jadhav
Sandeep B. Patil
Sameer J. Nadaf
author_sort Dheeraj S. Randive
collection DOAJ
description Abstract Background Site-specific transport of medicinal products to malignant cells and tissues is an intriguing area since it has an ability to safeguard healthy cells. Selective upregulation of folate receptors on colon cancer cells is usual. Consequently, folate receptors have become one of extensively studied target moieties for targeting the delivery of chemotherapeutics. Hence, the study aimed to anchor folic acid, chitosan and oxaliplatin to the functionalized nanotube (FA-CHI-FSWCNT-OXA) for targeting folate receptors on colon cancer cells. The purification process of single-walled carbon nanotubes (SWCNTs) involved the use of an ultrasonic-assisted acid digestion method. The developed complex was evaluated using FTIR, DSC, SEM, XRD and in vitro dissolution studies. SRB and MTT assays were used to assess in vitro cytotoxicity of oxaliplatin and FA-CHI-FSWCNT-OXA) against HT29 and COLO320DM cell lines. Further, progression of apoptosis in cells was investigated using flow cytometry. Results The FTIR results corroborated drug attachment over carbon nanotube (CNT), whereas the TEM results validated the nanosizing (1–300 nm) of the developed system. Drug entrapment in CNT was found to be 93.43 ± 1.65%, and in vitro drug release was found to be 94.73 ± 0.90% after 24 h. The complex reduced viability of 92.35 ± 0.942% cells than oxaliplatin’s 66.58 ± 0.38% inhibition, revealed by MTT assay. In the SRB assay, the developed system showed 91.22 ± 0.90% inhibition, whereas oxaliplatin showed 76.69 ± 0.52% inhibition against HT29 cells. Conclusions Conclusively, the developed system exhibited better cytotoxicity effects as compared with plain oxaliplatin. Our findings are suggestive of the potential development of CNT-anchored antineoplastic agents for target-specific delivery.
first_indexed 2024-03-10T22:11:27Z
format Article
id doaj.art-798bc27d02944566b8a526dd11a016d4
institution Directory Open Access Journal
issn 2314-7253
language English
last_indexed 2024-03-10T22:11:27Z
publishDate 2023-10-01
publisher SpringerOpen
record_format Article
series Future Journal of Pharmaceutical Sciences
spelling doaj.art-798bc27d02944566b8a526dd11a016d42023-11-19T12:36:34ZengSpringerOpenFuture Journal of Pharmaceutical Sciences2314-72532023-10-019111510.1186/s43094-023-00543-8Efficient in vitro oxaliplatin delivery with functionalized single-walled carbon nanotube for enhanced colon cancer treatmentDheeraj S. Randive0Kiran P. Shejawal1Somnath D. Bhinge2Mangesh A. Bhutkar3Namdeo R. Jadhav4Sandeep B. Patil5Sameer J. Nadaf6Department of Pharmaceutics, Rajarambapu College of PharmacyDepartment of Pharmaceutics, Rajarambapu College of PharmacyDepartment of Chemistry, Rajarambapu College of PharmacyDepartment of Pharmaceutics, Rajarambapu College of PharmacyKrishna Vishwa Vidyapeeth (Deemed to Be University), Krishna Institute of PharmacyDepartment of Pharmacology, Dr. Shivajirao Kadam College of PharmacyDepartment of Pharmaceutics, Bharati Vidyapeeth College of PharmacyAbstract Background Site-specific transport of medicinal products to malignant cells and tissues is an intriguing area since it has an ability to safeguard healthy cells. Selective upregulation of folate receptors on colon cancer cells is usual. Consequently, folate receptors have become one of extensively studied target moieties for targeting the delivery of chemotherapeutics. Hence, the study aimed to anchor folic acid, chitosan and oxaliplatin to the functionalized nanotube (FA-CHI-FSWCNT-OXA) for targeting folate receptors on colon cancer cells. The purification process of single-walled carbon nanotubes (SWCNTs) involved the use of an ultrasonic-assisted acid digestion method. The developed complex was evaluated using FTIR, DSC, SEM, XRD and in vitro dissolution studies. SRB and MTT assays were used to assess in vitro cytotoxicity of oxaliplatin and FA-CHI-FSWCNT-OXA) against HT29 and COLO320DM cell lines. Further, progression of apoptosis in cells was investigated using flow cytometry. Results The FTIR results corroborated drug attachment over carbon nanotube (CNT), whereas the TEM results validated the nanosizing (1–300 nm) of the developed system. Drug entrapment in CNT was found to be 93.43 ± 1.65%, and in vitro drug release was found to be 94.73 ± 0.90% after 24 h. The complex reduced viability of 92.35 ± 0.942% cells than oxaliplatin’s 66.58 ± 0.38% inhibition, revealed by MTT assay. In the SRB assay, the developed system showed 91.22 ± 0.90% inhibition, whereas oxaliplatin showed 76.69 ± 0.52% inhibition against HT29 cells. Conclusions Conclusively, the developed system exhibited better cytotoxicity effects as compared with plain oxaliplatin. Our findings are suggestive of the potential development of CNT-anchored antineoplastic agents for target-specific delivery.https://doi.org/10.1186/s43094-023-00543-8Carbon nanotubeOxaliplatinColon cancerCytotoxicityApoptosis
spellingShingle Dheeraj S. Randive
Kiran P. Shejawal
Somnath D. Bhinge
Mangesh A. Bhutkar
Namdeo R. Jadhav
Sandeep B. Patil
Sameer J. Nadaf
Efficient in vitro oxaliplatin delivery with functionalized single-walled carbon nanotube for enhanced colon cancer treatment
Future Journal of Pharmaceutical Sciences
Carbon nanotube
Oxaliplatin
Colon cancer
Cytotoxicity
Apoptosis
title Efficient in vitro oxaliplatin delivery with functionalized single-walled carbon nanotube for enhanced colon cancer treatment
title_full Efficient in vitro oxaliplatin delivery with functionalized single-walled carbon nanotube for enhanced colon cancer treatment
title_fullStr Efficient in vitro oxaliplatin delivery with functionalized single-walled carbon nanotube for enhanced colon cancer treatment
title_full_unstemmed Efficient in vitro oxaliplatin delivery with functionalized single-walled carbon nanotube for enhanced colon cancer treatment
title_short Efficient in vitro oxaliplatin delivery with functionalized single-walled carbon nanotube for enhanced colon cancer treatment
title_sort efficient in vitro oxaliplatin delivery with functionalized single walled carbon nanotube for enhanced colon cancer treatment
topic Carbon nanotube
Oxaliplatin
Colon cancer
Cytotoxicity
Apoptosis
url https://doi.org/10.1186/s43094-023-00543-8
work_keys_str_mv AT dheerajsrandive efficientinvitrooxaliplatindeliverywithfunctionalizedsinglewalledcarbonnanotubeforenhancedcoloncancertreatment
AT kiranpshejawal efficientinvitrooxaliplatindeliverywithfunctionalizedsinglewalledcarbonnanotubeforenhancedcoloncancertreatment
AT somnathdbhinge efficientinvitrooxaliplatindeliverywithfunctionalizedsinglewalledcarbonnanotubeforenhancedcoloncancertreatment
AT mangeshabhutkar efficientinvitrooxaliplatindeliverywithfunctionalizedsinglewalledcarbonnanotubeforenhancedcoloncancertreatment
AT namdeorjadhav efficientinvitrooxaliplatindeliverywithfunctionalizedsinglewalledcarbonnanotubeforenhancedcoloncancertreatment
AT sandeepbpatil efficientinvitrooxaliplatindeliverywithfunctionalizedsinglewalledcarbonnanotubeforenhancedcoloncancertreatment
AT sameerjnadaf efficientinvitrooxaliplatindeliverywithfunctionalizedsinglewalledcarbonnanotubeforenhancedcoloncancertreatment